Popular medications such as Ozempic, Wegovy, Mounjaro, and Zepbound may offer an unexpected benefit beyond helping people lose weight and…
More than one-quarter of people with Type 2 diabetes now use GLP-1 receptor agonists, a class of medications that includes…
Researchers at the National Institutes of Health (NIH) have uncovered new details about how GLP-1 weight loss drugs such as…
Medications used to treat type 2 diabetes and obesity, including well-known brands like Ozempic and Wegovy, may offer unexpected mental…
More than one in four people with Type 2 diabetes use GLP-1 receptor agonists, a class of widely prescribed medications.…
GLP-1 medications, such as semaglutide (Ozempic, Wegovy, and Rybelsus), commonly prescribed for diabetes and obesity may also be linked to…
Three recently released Cochrane reviews conclude that GLP-1 medications, such as Ozempic, can lead to meaningful weight loss. However, the…
Experts from UCL and the University of Cambridge warn that many people prescribed newer weight loss medications may not be…
A new real-world comparison finds that bariatric surgery leads to dramatically more weight loss than popular injectable medications. After two…
A new study led by a researcher at University College London (UCL) has found that the anti-obesity medication semaglutide (Ozempic…